Mayo Clinic

Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. Its platform aims to enhance cardiac care by assisting healthcare professionals in identifying potential heart issues, improving patient outcomes throughout the continuum of cardiovascular care.

Endogenex develops a novel endoscopic procedure using pulsed electric fields to regenerate the duodenal mucosa, aiming to improve glycemic control in patients with Type 2 Diabetes.

JOGO Health is a virtual care company that specializes in digital therapeutics aimed at treating pain, neuromuscular conditions, and pelvic floor disorders. Utilizing clinically proven digital interventions, the company develops an AI-driven mobile app paired with wearable sensors that deliver tailored treatment protocols. These offerings include games and exercises designed for muscle relaxation, movement coordination, and neuromuscular reeducation, all leveraging the brain's neuroplasticity. By enhancing patient adherence to rehabilitation programs, JOGO Health enables healthcare providers to achieve improved health outcomes for conditions such as chronic pain, stroke recovery, and pelvic health issues.

AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.

Nucleus RadioPharma specializes in modernizing the development, manufacturing, and supply chain of radiopharmaceuticals for cancer patients. It operates as a contract development and manufacturing organization, offering commercial-scale facilities near major medical centers to support innovators throughout their product lifecycle.

Founded in 2011, InfoBionic specializes in remote patient monitoring. Its flagship product, MoMe™, is a cloud-based SaaS service that wirelessly monitors patients, initially focusing on cardiac arrhythmia detection.

AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.

EBAMed develops a non-invasive ultrasound-based device to monitor and treat heart motion using proton beams. Founded in 2018, the company is based in Geneva, Switzerland.

MediView, LLC is a medical device company based in Cleveland, Ohio, that specializes in developing augmented reality surgical navigation systems aimed at enhancing surgical processes for healthcare providers. Founded in 2017, the company focuses on creating advanced technologies for surgical navigation, particularly for the ablation and biopsy of cancerous tumors. MediView's flagship product, MediView, utilizes real-time, fused-holographic visualization to enable surgeons to navigate procedures with greater accuracy and efficacy. This innovative approach allows for enhanced examination of patients through augmented reality 3D visualization, facilitating improved surgical outcomes and supporting remote collaboration among healthcare professionals.

Mediwhale is a healthcare company focused on preventive medicine through innovative AI technology. The company has developed a unique AI screening platform that utilizes retinal scans for non-invasive risk assessments and diagnoses related to cardiovascular, renal, metabolic health, and eye diseases. Mediwhale's platform includes RetiCVD® for cardiovascular disease risk assessment, RetiCKD® for chronic kidney disease risk assessment, and RetiEYE® for detecting referable eye diseases. These tools have been clinically validated through collaborations with medical institutions across multiple countries and are recognized for their accuracy in predicting health risks before symptoms appear.

Cadence Neuroscience develops implantable medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company pursues core technology developed at Mayo Clinic that is being evaluated clinically. The device detects brain signals and delivers electrical stimulation to modulate neural circuits, enabling personalized brain stimulation to improve seizure control relative to existing protocols.

Healium is a technology company that develops mental fitness tools and immersive, bio-data-driven experiences to support self-management of anxiety, sleep issues, burnout, and overall well-being. The platform links real-time biometric data from wearables such as heart rate and brain activity via EEG headbands to personalized video or VR assets, producing reactive media escapes controlled by the user’s physiology. By integrating wearable devices and sensors, Healium delivers data-driven content that adapts to the user in real time, aiming to reduce anxiety, improve mood, and build resilience for individuals and organizations. Peer-reviewed studies have reported rapid mood benefits and anxiety reduction in as little as four minutes.

Nucleus RadioPharma specializes in modernizing the development, manufacturing, and supply chain of radiopharmaceuticals for cancer patients. It operates as a contract development and manufacturing organization, offering commercial-scale facilities near major medical centers to support innovators throughout their product lifecycle.

Genomadix specializes in developing molecular tests for infectious diseases, precision medicine, and water safety. Its innovative platform and portable analyzer use PCR technology to deliver swift, accurate test results outside traditional healthcare settings.

Olive Diagnostics is a company that has developed an innovative passive urine analysis sensor designed to enhance early disease detection and chronic disease management. This sensor, which can be easily mounted to any toilet, utilizes spectroscopy combined with artificial intelligence-based analytics to monitor the urine stream. By continuously collecting and analyzing health data, the device provides users with real-time health alerts that promote awareness of their bodily functions. The technology not only supports individual health management but also offers valuable insights for pharmaceutical and contract research organizations to track drug compliance and usage. With its focus on proactive health monitoring, Olive Diagnostics aims to make urine lab services accessible even in nonindustrial nations, thereby transforming personal health care through advanced, continuous biomarker tracking.

Medically Home Group, Inc. is a Boston-based company that specializes in providing a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on shifting medical care from traditional hospital settings to patients' homes, particularly for those with serious or complex illnesses such as heart failure, pneumonia, and respiratory infections. Medically Home's technology-enabled platform connects patients with caregivers, facilitating ongoing monitoring and communication. This system allows patients and their families to access a centralized medical command center, which offers on-demand acute medical care management, ensuring that necessary medical support is available in a more comfortable and familiar environment.

The Patient Company designs and manufactures SimPull, an automated lateral patient transfer device. SimPull aims to protect clinicians from injuries, shorten transfer times, and eliminate waste associated with disposable components of competing products. Founded in 2019 and based in Grand Rapids, Michigan, the company also maintains operations in Scottsdale, Arizona. The motorized device is fully automated and can be operated by a single care team member, enabling safe, efficient transfers with automated management while reducing risk to staff and supporting respectful patient handling.

Tympany Medical develops a platform for minimally invasive ear surgeries. Its device enables surgeons to perform complex procedures using sterile endoscopy, reducing unnecessary mastoidectomies and enhancing surgical outcomes.

Laplace develops transcatheter tricuspid valve technology, enhancing life expectancy and improving quality of life for global patients with tricuspid regurgitation through a minimally invasive procedure.

JOGO Health is a virtual care company that specializes in digital therapeutics aimed at treating pain, neuromuscular conditions, and pelvic floor disorders. Utilizing clinically proven digital interventions, the company develops an AI-driven mobile app paired with wearable sensors that deliver tailored treatment protocols. These offerings include games and exercises designed for muscle relaxation, movement coordination, and neuromuscular reeducation, all leveraging the brain's neuroplasticity. By enhancing patient adherence to rehabilitation programs, JOGO Health enables healthcare providers to achieve improved health outcomes for conditions such as chronic pain, stroke recovery, and pelvic health issues.

Helix is a leading population genomics company that operates at the intersection of clinical care, research, and genomics. Its comprehensive platform enables healthcare systems, life sciences companies, and payers to advance genomic research and integrate genomic data into clinical care.

Medically Home Group, Inc. is a Boston-based company that specializes in providing a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on shifting medical care from traditional hospital settings to patients' homes, particularly for those with serious or complex illnesses such as heart failure, pneumonia, and respiratory infections. Medically Home's technology-enabled platform connects patients with caregivers, facilitating ongoing monitoring and communication. This system allows patients and their families to access a centralized medical command center, which offers on-demand acute medical care management, ensuring that necessary medical support is available in a more comfortable and familiar environment.

Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. Its platform aims to enhance cardiac care by assisting healthcare professionals in identifying potential heart issues, improving patient outcomes throughout the continuum of cardiovascular care.

Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. Its platform aims to enhance cardiac care by assisting healthcare professionals in identifying potential heart issues, improving patient outcomes throughout the continuum of cardiovascular care.

Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Securisyn Medical manufactures and supplies oxygen delivery systems for mechanically ventilated patients in critical care settings. Its innovative airway stabilization system, featuring a ribbed endotracheal tube and interlocking stabilizer, enhances patient safety by preventing unplanned extubation and reducing healthcare costs.

AtriAN Medical is an Irish medical device company based in Galway, a prominent center for medical technology innovation. The company is focused on commercializing advanced technology developed at the Mayo Clinic in the United States. AtriAN specializes in a medical device designed to treat atrial fibrillation by employing micro Pulsed Electric Fields (mPEF). This innovative approach selectively ablates hyperactive tissue while preserving surrounding myocardium, minimizing damage to the heart muscle. Utilizing a catheter, AtriAN's device delivers short pulses of electrical energy directly to the problematic areas, offering a targeted treatment option that enhances patient safety and outcomes.

Cadence Neuroscience develops implantable medical device therapies for epilepsy, central pain, and other neurological disorders. Founded in 2017 and based in Redmond, Washington, the company pursues core technology developed at Mayo Clinic that is being evaluated clinically. The device detects brain signals and delivers electrical stimulation to modulate neural circuits, enabling personalized brain stimulation to improve seizure control relative to existing protocols.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Founded in 2012, Geneticure develops pharmacogenetic testing tools that enable healthcare providers to offer personalized medicine. Its flagship product is a cheek-swab test predicting individual responses to high blood pressure medications and devices.

Helix is a leading population genomics company that operates at the intersection of clinical care, research, and genomics. Its comprehensive platform enables healthcare systems, life sciences companies, and payers to advance genomic research and integrate genomic data into clinical care.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Glooko develops a remote patient-monitoring platform for individuals with diabetes. It integrates with diabetes devices, fitness wearables, and activity trackers to capture data and provide reports, aiming to drive behavior change and improve health outcomes. The platform facilitates communication between patients and healthcare providers, enhancing care. Glooko is available on Android and iOS.

Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters, primarily for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. Its flagship product, the LINX reflux management system, utilizes specialized magnets to provide a minimally invasive solution for patients suffering from GERD. Additionally, Torax offers the FENIX continence restoration system, designed to address fecal incontinence. The company's products are available in both the United States and Europe, reflecting its commitment to improving patient outcomes in the field of digestive diseases. Torax Medical operates as a subsidiary of Ethicon, Inc.

Helix is a leading population genomics company that operates at the intersection of clinical care, research, and genomics. Its comprehensive platform enables healthcare systems, life sciences companies, and payers to advance genomic research and integrate genomic data into clinical care.

Lifecode, Inc. is a molecular diagnostics company based in Foster City, California, specializing in next-generation sequencing (NGS) technology. The company develops a range of NGS-based cancer assays, including its flagship product, the Lifecode Pan Cancer Somatic Panel, which is designed for use in various metastatic and rare cancers, as well as for patients seeking clinical trials. Lifecode focuses on translating complex genomic and therapeutic data into actionable insights for healthcare providers, patients, and payers. The company's team comprises experts in data science, software engineering, computational biology, bioinformatics, machine learning, molecular biology, and pathology, enabling it to bridge the gap between advanced sequencing technology and clinical application. Lifecode was previously known as Silicon Valley Biosystems, Inc. and rebranded in 2015. As of early 2016, it operates as a subsidiary of MedGenome Labs Private Ltd.

Nevro Corporation is a global medical device company specializing in innovative solutions for chronic pain management. Its primary product is the Senza spinal cord stimulation (SCS) system, which employs proprietary HF10 therapy to deliver evidence-based neuromodulation treatment. The Senza system consists of implantable components controlled by patients and managed by healthcare professionals using specialized software. Nevro generates a significant portion of its revenue in the United States.

Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters, primarily for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. Its flagship product, the LINX reflux management system, utilizes specialized magnets to provide a minimally invasive solution for patients suffering from GERD. Additionally, Torax offers the FENIX continence restoration system, designed to address fecal incontinence. The company's products are available in both the United States and Europe, reflecting its commitment to improving patient outcomes in the field of digestive diseases. Torax Medical operates as a subsidiary of Ethicon, Inc.

Nevro Corporation is a global medical device company specializing in innovative solutions for chronic pain management. Its primary product is the Senza spinal cord stimulation (SCS) system, which employs proprietary HF10 therapy to deliver evidence-based neuromodulation treatment. The Senza system consists of implantable components controlled by patients and managed by healthcare professionals using specialized software. Nevro generates a significant portion of its revenue in the United States.

Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters, primarily for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. Its flagship product, the LINX reflux management system, utilizes specialized magnets to provide a minimally invasive solution for patients suffering from GERD. Additionally, Torax offers the FENIX continence restoration system, designed to address fecal incontinence. The company's products are available in both the United States and Europe, reflecting its commitment to improving patient outcomes in the field of digestive diseases. Torax Medical operates as a subsidiary of Ethicon, Inc.

Nevro Corporation is a global medical device company specializing in innovative solutions for chronic pain management. Its primary product is the Senza spinal cord stimulation (SCS) system, which employs proprietary HF10 therapy to deliver evidence-based neuromodulation treatment. The Senza system consists of implantable components controlled by patients and managed by healthcare professionals using specialized software. Nevro generates a significant portion of its revenue in the United States.

Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan’s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.

NBI Development is an implantable medical device company focused on the development of novel neuromodulation therapies. The company develops neuromodulation, the use of electrical impulses to manage activity in the nervous system.

Nevro Corporation is a global medical device company specializing in innovative solutions for chronic pain management. Its primary product is the Senza spinal cord stimulation (SCS) system, which employs proprietary HF10 therapy to deliver evidence-based neuromodulation treatment. The Senza system consists of implantable components controlled by patients and managed by healthcare professionals using specialized software. Nevro generates a significant portion of its revenue in the United States.

Naviscan, Inc. is the leader in organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution PET scanner which provides unprecedented visualization of small body parts. While Naviscan’s PET scanner can image virtually any body part that can fit into the gantry, it is most often utilized as an adjunct to conventional imaging technologies by clinicians who stage and manage breast cancer. Surgeons, radiologists, nuclear physicians, and oncologists in hospitals and breast clinics use our compact, mobile and easy-to-use PET scanner to precisely characterize breast cancer, enhance surgical planning, monitor patient response to therapy, and evaluate suspected recurrence.

Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company specializes in developing and marketing innovative products aimed at restoring the barrier function of sphincters, primarily for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence. Its flagship product, the LINX reflux management system, utilizes specialized magnets to provide a minimally invasive solution for patients suffering from GERD. Additionally, Torax offers the FENIX continence restoration system, designed to address fecal incontinence. The company's products are available in both the United States and Europe, reflecting its commitment to improving patient outcomes in the field of digestive diseases. Torax Medical operates as a subsidiary of Ethicon, Inc.